CLDX (CLDX): Results for Last 10 Financial Years (Summary)

Celldex Therapeutics, Inc.

NASDAQ (USD): Celldex Therapeutics, Inc. (CLDX)

Last Price

23.55

Today's Change

-2.19 (8.50%)

Day's Change

23.49 - 25.89

Trading Volume

1,218,346

Financial

Market Cap

1 Billion

Shares Outstanding

66 Million

Latest Quarter

30-Sep-2024 [Q3]

Announcement Date

06-Nov-2024

Reported Currency

USD

Revenue QoQ | YoY

27.74% | 110.35%

NP QoQ | YoY

-17.52% | -10.09%

Latest Audited

31-Dec-2023

Announcement Date

26-Feb-2024

Reported Currency

USD

Revenue | Net Profit

6,883,000.00 | -141,429,000.00

EPS | EPS Diluted

-2.92 Cent | -2.92 Cent

YoY

-15.19%

NP Margin

-2,054.76%

Reported Currency in USD

Show?

YoY %

Horiz. %

	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Last 10 FY Result (Thousand)
Revenue	6,883	2,357	4,651	7,418	3,573	9,538	12,743	6,786	5,480	3,586	7.50%
YoY %	192.02%	-49.32%	-37.30%	107.61%	-62.54%	-25.15%	87.78%	23.83%	52.82%	-	-
Horiz. %	191.94%	65.73%	129.70%	206.86%	99.64%	265.98%	355.35%	189.24%	152.82%	100.00%	-
PBT	-141,429	-112,325	-70,738	-60,947	-50,878	-151,949	-117,313	-128,530	-127,197	-118,080	2.02%
YoY %	-25.91%	-58.79%	-16.06%	-19.79%	66.52%	-29.52%	8.73%	-1.05%	-7.72%	-	-
Horiz. %	119.77%	95.13%	59.91%	51.62%	43.09%	128.68%	99.35%	108.85%	107.72%	100.00%	-
Tax	0	10,458	-227	-1,167	-506	-765	-24,282	-8,772	-2,344	-4,350	-
YoY %	0.00%	4,707.05%	80.55%	-130.63%	33.86%	96.85%	-176.81%	-274.23%	46.11%	-	-
Horiz. %	0.00%	-240.41%	5.22%	26.83%	11.63%	17.59%	558.21%	201.66%	53.89%	100.00%	-
NP	-141,429	-122,783	-70,511	-59,780	-50,372	-151,184	-93,031	-128,530	-127,197	-118,080	2.02%
YoY %	-15.19%	-74.13%	-17.95%	-18.68%	66.68%	-62.51%	27.62%	-1.05%	-7.72%	-	-
Horiz. %	119.77%	103.98%	59.71%	50.63%	42.66%	128.04%	78.79%	108.85%	107.72%	100.00%	-
Tax Rate	-	-	-	-	-	-	-	-	-	-	-
YoY %	-	-	-	-	-	-	-	-	-	-	-
Horiz. %	-	-	-	-	-	-	-	-	-	-	-
Total Cost	148,312	125,140	75,162	67,198	53,945	160,722	105,774	135,316	132,677	121,666	2.22%
YoY %	18.52%	66.49%	11.85%	24.57%	-66.44%	51.95%	-21.83%	1.99%	9.05%	-	-
Horiz. %	121.90%	102.86%	61.78%	55.23%	44.34%	132.10%	86.94%	111.22%	109.05%	100.00%	-

	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Ratio Analysis
NP Margin	-2,054.76	-5,209.29	-1,516.04	-805.88	-1,409.80	-1,585.07	-730.06	-1,894.05	-2,321.11	-3,292.81	-5.10%
YoY %	60.56%	-243.61%	-88.12%	42.84%	11.06%	-117.12%	61.46%	18.40%	29.51%	-	-
Horiz. %	62.40%	158.20%	46.04%	24.47%	42.81%	48.14%	22.17%	57.52%	70.49%	100.00%	-

	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Per Share
EPS	-2.92	-2.62	-1.64	-2.02	-3.47	-14.48	-10.86	-18.99	-19.66	-19.81	-19.15%
YoY %	-11.45%	-59.76%	18.81%	41.79%	76.04%	-33.33%	42.81%	3.41%	0.76%	-	-
Horiz. %	14.74%	13.23%	8.28%	10.20%	17.52%	73.09%	54.82%	95.86%	99.24%	100.00%	-
EPS Diluted	-2.92	-2.62	-1.64	-2.02	-3.47	-14.48	-10.86	-18.99	-19.66	-19.81	-19.15%
YoY %	-11.45%	-59.76%	18.81%	41.79%	76.04%	-33.33%	42.81%	3.41%	0.76%	-	-
Horiz. %	14.74%	13.23%	8.28%	10.20%	17.52%	73.09%	54.82%	95.86%	99.24%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Featured Posts

Latest Videos